Detalhe da pesquisa
1.
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740030
2.
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
Mod Pathol
; 37(3): 100424, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219954
3.
Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience.
J Urol
; 211(2): 241-255, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922370
4.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-up From a Phase 3 Trial.
J Urol
; : 101097JU0000000000004020, 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704840
5.
Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin.
BJU Int
; 133(1): 63-70, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442564
6.
Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.
BJU Int
; 133(6): 733-741, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38374533
7.
Evolving systemic management of urothelial cancers.
Curr Opin Oncol
; 35(3): 186-199, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966497
8.
International Bladder Cancer Group Intermediate-risk Nonmuscle-invasive Bladder Cancer Scoring System Predicts Outcomes of Patients on Active Surveillance.
J Urol
; 210(5): 763-770, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535836
9.
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic.
J Urol
; 209(1): 140-149, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250944
10.
Geographic distribution of racial differences in mortality in muscle-invasive bladder cancer patients: an opportunity for improvement.
Cancer Causes Control
; 33(4): 613-622, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050417
11.
Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review.
Cancer Causes Control
; 33(8): 1071-1081, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699798
12.
All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors.
J Urol
; 208(2): 284-291, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770498
13.
Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience.
J Urol
; 207(3): 551-558, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694143
14.
Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder.
BJU Int
; 130(5): 604-610, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773684
15.
Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin?
BJU Int
; 130(4): 463-469, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854189
16.
Reduced-dose bacillus Calmette-Guérin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre.
BJU Int
; 130(3): 323-330, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847263
17.
Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient's undergoing urologic oncology surgery: a systematic review.
World J Urol
; 40(6): 1325-1342, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32648071
18.
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
Lancet Oncol
; 22(7): 919-930, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051177
19.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253641
20.
Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy.
J Urol
; 206(3): 577-585, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872050